Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis
NCT02055131
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Thrombosis
Interventions
DRUG:
aspirin
Sponsor
Tunis University